These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26823338)

  • 1. Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial.
    Zaman K; Fleming JA; Victor JC; Yunus M; Bari TI; Azim T; Rahman M; Mowla SM; Bellini WJ; McNeal M; Icenogle JP; Lopman B; Parashar U; Cortese MM; Steele AD; Neuzil KM
    J Infect Dis; 2016 Jun; 213(11):1686-93. PubMed ID: 26823338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
    J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants.
    Johnson CE; Darbari A; Darbari DS; Nalin D; Whitwell J; Chui LW; Cleves MA; Kumar ML
    Vaccine; 2000 May; 18(22):2411-5. PubMed ID: 10738098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
    Durando P; Esposito S; Bona G; Cuccia M; Desole MG; Ferrera G; Gabutti G; Pellegrino A; Salvini F; Henry O; Povey M; Marchetti F
    Vaccine; 2016 Aug; 34(36):4278-84. PubMed ID: 27423382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan.
    Ihara T
    Vaccine; 2009 May; 27(24):3234-6. PubMed ID: 19366578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
    Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
    PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants.
    Haidara FC; Tapia MD; Sow SO; Doumbia M; Coulibaly F; Diallo F; Traoré A; Kodio M; Kelly CL; Fitzpatrick M; Kotloff K; Victor JC; Neuzil K
    J Infect Dis; 2018 Jul; 218(4):606-613. PubMed ID: 29659924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
    Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
    Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of platelet-binding anti-measles and anti-rubella virus IgG antibodies in infants with vaccine-induced thrombocytopenic purpura.
    Okazaki N; Takeguchi M; Sonoda K; Handa Y; Kakiuchi T; Miyahara H; Akiyoshi K; Korematsu S; Suenobu S; Izumi T
    Vaccine; 2011 Jul; 29(31):4878-80. PubMed ID: 21539881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.
    Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF
    Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
    Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F
    Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phases 3 and 4 immunization immunogenicity with combined measles-rubella vaccine].
    Ozaki T; Nishimura N; Gotoh K; Ohe K; Funahashi K; Maeda K; Okuno Y
    Kansenshogaku Zasshi; 2011 May; 85(3):250-5. PubMed ID: 21706844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
    JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
    Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.